$LPCN
Lipocine Inc.

2024 Q4 Form 10-Q Financial Statement

#000149315224043893 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.045M
YoY Change 0.5%
% of Gross Profit
Research & Development $1.585M
YoY Change -44.93%
% of Gross Profit
Depreciation & Amortization $8.520K
YoY Change -14.8%
% of Gross Profit
Operating Expenses $2.630M
YoY Change -32.92%
Operating Profit -$2.630M
YoY Change -62.65%
Interest Expense $273.6K
YoY Change
% of Operating Profit
Other Income/Expense, Net $411.7K
YoY Change 4.91%
Pretax Income -$2.219M
YoY Change -66.64%
Income Tax
% Of Pretax Income
Net Earnings -$2.219M
YoY Change -66.64%
Net Earnings / Revenue
Basic Earnings Per Share -$0.41
Diluted Earnings Per Share -$0.44
COMMON SHARES
Basic Shares Outstanding 5.348M shares 5.348M shares
Diluted Shares Outstanding 5.348M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.82M
YoY Change -16.88%
Cash & Equivalents $3.743M
Short-Term Investments $16.08M
Other Short-Term Assets $588.8K
YoY Change -18.22%
Inventory
Prepaid Expenses
Receivables $91.48K
Other Receivables $0.00
Total Short-Term Assets $20.50M
YoY Change -16.7%
LONG-TERM ASSETS
Property, Plant & Equipment $170.6K
YoY Change 48.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $23.75K
YoY Change 0.0%
Total Long-Term Assets $194.4K
YoY Change 40.16%
TOTAL ASSETS
Total Short-Term Assets $20.50M
Total Long-Term Assets $194.4K
Total Assets $20.70M
YoY Change -16.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $285.3K
YoY Change -74.08%
Accrued Expenses $1.292M
YoY Change 13.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.581M
YoY Change -29.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.581M
Total Long-Term Liabilities $0.00
Total Liabilities $1.581M
YoY Change -30.37%
SHAREHOLDERS EQUITY
Retained Earnings -$201.6M
YoY Change 2.05%
Common Stock $8.863K
YoY Change 0.03%
Preferred Stock
YoY Change
Treasury Stock (at cost) $40.71K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $19.12M
YoY Change
Total Liabilities & Shareholders Equity $20.70M
YoY Change -16.38%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$2.219M
YoY Change -66.64%
Depreciation, Depletion And Amortization $8.520K
YoY Change -14.8%
Cash From Operating Activities -$2.833M
YoY Change 8.96%
INVESTING ACTIVITIES
Capital Expenditures $80.07K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $1.103M
YoY Change -11.09%
Cash From Investing Activities $1.022M
YoY Change -17.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.833M
Cash From Investing Activities 1.022M
Cash From Financing Activities 0.000
Net Change In Cash -1.810M
YoY Change 92.6%
FREE CASH FLOW
Cash From Operating Activities -$2.833M
Capital Expenditures $80.07K
Free Cash Flow -$2.913M
YoY Change 12.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001535955
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23753 usd
dei Document Type
DocumentType
10-Q
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36357
dei Entity Registrant Name
EntityRegistrantName
LIPOCINE INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0370688
dei Entity Address Address Line1
EntityAddressAddressLine1
675 Arapeen Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 202
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84108
dei City Area Code
CityAreaCode
801
dei Local Phone Number
LocalPhoneNumber
994-7383
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
LPCN
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5347940 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4771758 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
16080691 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
17263788 usd
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
91482 usd
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
52254 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
588824 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
773424 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
20503938 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
22861224 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1207726 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1182191 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
170627 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116095 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1395977 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
17166 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1581218 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2631629 usd
CY2024Q3 us-gaap Liabilities
Liabilities
1581218 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2631629 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5316166 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5347940 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5315830 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
8863 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
8860 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
220690052 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
220171250 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
336 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
336 shares
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
40712 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7259 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-201551045 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-199777214 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
19117100 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
20369443 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20698318 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23001072 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23753 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1292285 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
209340 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
409866 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1028817 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
924210 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4771758 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3148496 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3742941 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4072706 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
681 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
656 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2683 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
5818 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5347940 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5292058 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.26
CY2024Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
138081 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
74827 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5347940 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5347940 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5292058 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.27
us-gaap Share Based Compensation
ShareBasedCompensation
309465 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 LPCN Revenue Recognition Services Licensing Fee
RevenueRecognitionServicesLicensingFee
usd
CY2023Q3 LPCN Revenue Recognition Services Licensing Fee
RevenueRecognitionServicesLicensingFee
usd
CY2024Q3 LPCN Royalty Revenue
RoyaltyRevenue
usd
CY2023Q3 LPCN Royalty Revenue
RoyaltyRevenue
usd
LPCN Royalty Revenue
RoyaltyRevenue
usd
CY2024Q3 LPCN Minimum Guaranteed Royalties Revenue Reversal Of Variable Consideration
MinimumGuaranteedRoyaltiesRevenueReversalOfVariableConsideration
usd
LPCN Minimum Guaranteed Royalties Revenue Reversal Of Variable Consideration
MinimumGuaranteedRoyaltiesRevenueReversalOfVariableConsideration
usd
CY2024Q3 us-gaap Revenues
Revenues
usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
usd
CY2023Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
usd
LPCN Write Off Of Contract Asset Due To Variable Consideration Revenue Reversal
WriteOffOfContractAssetDueToVariableConsiderationRevenueReversal
usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
usd
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3742941 usd
CY2024Q3 us-gaap Assets
Assets
20698318 usd
CY2023Q4 us-gaap Assets
Assets
23001072 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
285347 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1218486 usd
CY2024Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3586 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5348276 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
40712 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9942 usd
LPCN Revenue Recognition Services Licensing Fee
RevenueRecognitionServicesLicensingFee
7500000 usd
LPCN Revenue Recognition Services Licensing Fee
RevenueRecognitionServicesLicensingFee
54990 usd
LPCN Royalty Revenue
RoyaltyRevenue
206738 usd
CY2023Q3 LPCN Minimum Guaranteed Royalties Revenue Reversal Of Variable Consideration
MinimumGuaranteedRoyaltiesRevenueReversalOfVariableConsideration
3121996 usd
LPCN Minimum Guaranteed Royalties Revenue Reversal Of Variable Consideration
MinimumGuaranteedRoyaltiesRevenueReversalOfVariableConsideration
3121996 usd
CY2023Q3 us-gaap Revenues
Revenues
-3121996 usd
us-gaap Revenues
Revenues
7706738 usd
us-gaap Revenues
Revenues
-3067006 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1585233 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2878798 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6278881 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8500319 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1045240 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1042572 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4128371 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3770281 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2630473 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
3921370 usd
us-gaap Operating Expenses
OperatingExpenses
10407252 usd
us-gaap Operating Expenses
OperatingExpenses
12270600 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2630473 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7043366 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2700514 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15337606 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
273574 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
317569 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
913784 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1067561 usd
CY2024Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
138081 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
74827 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
13580 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
200416 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
411655 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
392396 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
927364 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1267977 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2218818 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6650970 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1773150 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14069629 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
681 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2218818 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6650970 usd
us-gaap Net Income Loss
NetIncomeLoss
-1773831 usd
us-gaap Net Income Loss
NetIncomeLoss
-14069829 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
89 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2218818 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6650970 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1773831 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14069918 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.68
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5347940 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5292058 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5335941 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5254116 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.72
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5347940 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5292058 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5335941 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5254116 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2218818 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6650970 usd
us-gaap Net Income Loss
NetIncomeLoss
-1773831 usd
us-gaap Net Income Loss
NetIncomeLoss
-14069829 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
19661 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1309 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2683 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5818 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2199157 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6649661 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1771148 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14064011 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
28552011 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6650970 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1309 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
158090 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
421082 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
22481522 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
35634940 usd
us-gaap Net Income Loss
NetIncomeLoss
-14069829 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5818 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
500727 usd
us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
-9 usd
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
9 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
409866 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
22481522 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
21208363 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2218818 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
19661 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
107894 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
19117100 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
20369443 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
20369443 usd
us-gaap Net Income Loss
NetIncomeLoss
-1773831 usd
us-gaap Net Income Loss
NetIncomeLoss
-1773831 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2683 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
309465 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
209340 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
19117100 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
19117100 usd
us-gaap Net Income Loss
NetIncomeLoss
-1773831 usd
us-gaap Net Income Loss
NetIncomeLoss
-14069829 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
25535 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
20658 usd
us-gaap Share Based Compensation
ShareBasedCompensation
309465 usd
us-gaap Share Based Compensation
ShareBasedCompensation
500727 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13580 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-200416 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
579290 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
750092 usd
LPCN Write Off Of Contract Asset Due To Variable Consideration Revenue Reversal
WriteOffOfContractAssetDueToVariableConsiderationRevenueReversal
3121995 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
39228 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-39366 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-579428 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-184600 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-351222 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1110630 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
500680 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
73799 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
62575 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2923160 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9843686 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
80067 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
23134930 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
13537970 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
24900000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
23900000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1685003 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10358030 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
209340 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
409866 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
89 usd
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
reverse stock split ratio of 1-for-17
LPCN Revenue Reversal Of Variable Consideration
RevenueReversalOfVariableConsideration
7500000 usd
us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
140000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2218818 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6650970 usd
us-gaap Net Income Loss
NetIncomeLoss
-1773831 usd
us-gaap Net Income Loss
NetIncomeLoss
-14069829 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5335941 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5254116 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.68
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2218818 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6650970 usd
us-gaap Net Income Loss
NetIncomeLoss
-1773831 usd
us-gaap Net Income Loss
NetIncomeLoss
-14069829 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
13580 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
200416 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2356899 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6725797 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1787411 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-14270245 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5292058 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5335941 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5254116 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5335941 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5254116 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.72
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
16070749 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
9942 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
16080691 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
17256529 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
8574 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1315 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
17263788 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
16070749 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
16080691 usd
CY2024Q3 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
0 usd
CY2023Q3 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
0 usd
us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
0 usd
us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
0 usd
CY2024Q3 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0 usd
CY2023Q3 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0 usd
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0 usd
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0 usd
CY2024Q3 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
6700000 usd
CY2023Q3 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
6000000.0 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
24900000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
23900000 usd
CY2024Q3 LPCN Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairments
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairments
0 usd
CY2023Q3 LPCN Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairments
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairments
0 usd
LPCN Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairments
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairments
0 usd
LPCN Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairments
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairments
0 usd
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
19823632 usd
CY2024Q3 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
19827218 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
21959279 usd
CY2023Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
21976445 usd
LPCN Revenue Reversal Of Variable Consideration
RevenueReversalOfVariableConsideration
7500000 usd
us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
140000 usd
CY2024Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
740000 usd
CY2023Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2100000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
3700000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
5900000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
92019 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
61346 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
153365 usd
CY2024Q3 us-gaap Payments For Rent
PaymentsForRent
92000 usd
CY2023Q3 us-gaap Payments For Rent
PaymentsForRent
89000 usd
us-gaap Payments For Rent
PaymentsForRent
274000 usd
us-gaap Payments For Rent
PaymentsForRent
266000 usd
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
reverse stock split ratio of 1-for-17
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
63.96
CY2024Q3 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
0.001
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
108000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
158000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
309000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
501000 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
107894 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
158090 usd
us-gaap Share Based Compensation
ShareBasedCompensation
500727 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
278000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y8M12D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
286484 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.79
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13069 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
224430 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
32.33
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
17166 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13580 usd
CY2024Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3586 usd
CY2019Q4 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
1250000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-043893-index-headers.html Edgar Link pending
0001493152-24-043893-index.html Edgar Link pending
0001493152-24-043893.txt Edgar Link pending
0001493152-24-043893-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_chart.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lpcn-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
lpcn-20240930_lab.xml Edgar Link unprocessable
lpcn-20240930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lpcn-20240930_cal.xml Edgar Link unprocessable
lpcn-20240930_def.xml Edgar Link unprocessable